Mimedx (MDXG) EBT Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.99% |
| Dec 31, 2025 | 26.49% |
| Sep 30, 2025 | 26.03% |
| Jun 30, 2025 | 28.78% |
| Mar 31, 2025 | 20.44% |
| Dec 31, 2024 | 28.84% |
| Sep 30, 2024 | -1.10% |
| Jun 30, 2024 | 27.37% |
| Mar 31, 2024 | 23.41% |
| Dec 31, 2023 | 29.16% |
| Sep 30, 2023 | 82.03% |
| Jun 30, 2023 | 38.65% |
| Mar 31, 2023 | -21.21% |
| Dec 31, 2022 | -12.22% |
| Sep 30, 2022 | -21.43% |
| Jun 30, 2022 | -28.69% |
| Mar 31, 2022 | -30.09% |
| Dec 31, 2021 | 14.99% |
| Sep 30, 2021 | -19.55% |
| Jun 30, 2021 | -20.28% |
| Mar 31, 2021 | -51.19% |
| Dec 31, 2020 | -33.82% |
| Sep 30, 2020 | -37.35% |
| Jun 30, 2020 | -28.42% |
| Mar 31, 2020 | -42.18% |
| Dec 31, 2019 | -28.93% |
| Sep 30, 2019 | 26.53% |
| Jun 30, 2019 | -112.10% |
| Mar 31, 2019 | -70.73% |
| Dec 31, 2018 | -43.70% |
| Sep 30, 2018 | 30.69% |
| Jun 30, 2018 | 34.27% |
| Mar 31, 2018 | 31.64% |
| Dec 31, 2017 | 68.97% |
| Sep 30, 2017 | 38.51% |
| Jun 30, 2017 | 62.96% |
| Mar 31, 2017 | 49.72% |
| Dec 31, 2016 | -28.22% |
| Sep 30, 2016 | 35.77% |
| Jun 30, 2016 | 27.57% |
| Mar 31, 2016 | 19.35% |